Year in Review: Tardive Dyskinesia New VMAT2 formulations, case reports, screening tools, and long-term data in 2024 Nov 01, 2024
Leukemia Drug Shows Promise in Dementia With Lewy Bodies Cognitive outcomes, biomarkers improved with nilotinib in phase II trial Oct 30, 2024
We Can Better Protect Kids From Head Injury in Football Making youth football safer requires a collective effort Oct 29, 2024
Alzheimer's Trials Investigated; Chronic Pain Predicted; Dementia Drugs and AMD News and commentary from the world of neurology and neuroscience Oct 29, 2024
A Moral Code: Ethical Dilemmas in Medicine Three physicians face crossroads in patient care Oct 25, 2024 podcast
Should I Offer My Patient the Option to End His Life? The complexity of medical aid-in-dying laws Oct 25, 2024 podcast
A Case of Broca's Aphasia An excerpt from Theodore H. Schwartz's book, Gray Matters: A Biography of Brain Surgery Oct 25, 2024
Ozempic Linked With Lower Risk of Alzheimer's Diagnosis Large observational study suggests further research is warranted Oct 24, 2024
EPA Imposes Stricter Standards to Protect Kids From Lead Paint Exposure "There is no safe level of lead," said agency official Oct 24, 2024
First Cases of New Neurology Syndrome Identified Long non-coding RNA implicated in human disease Oct 23, 2024
Poor Sleep at Age 40 Linked to Accelerated Brain Aging Sleep quality in early midlife predicted brain age 15 years later Oct 23, 2024
MIND Diet and Cognitive Decline; Gene Therapy for Parkinson's; Curbing MS Fatigue News and commentary from the world of neurology and neuroscience Oct 22, 2024
Hearing Loss May Signal Early Parkinson's Disease Early interventions with hearing aids attenuated the risk Oct 21, 2024
Daily Oral Edaravone for ALS No Better Than On/Off Regimen Changes in CAFS, ALSFRS-R scores comparable at 48 weeks Oct 21, 2024
Myasthenia Gravis Patients May Use Less Steroids After Starting Efgartigimod Insurance claims data show lower glucocorticoid usage at 1 year Oct 20, 2024
Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker Nipocalimab plus standard of care reduced IgG and was well tolerated Oct 19, 2024
Gene Therapy Details Revealed in Duchenne Trial Differences between delandistrogene moxeparvovec and placebo emerge in secondary outcomes Oct 18, 2024
Continuous Parkinson's Disease Therapy Wins FDA Nod Round-the-clock infusion delivers carbidopa and levodopa pro-drugs Oct 17, 2024
Kids' Neurodevelopment Appears Unharmed by Maternal COVID Infection Study may ease fears about potential neurodevelopmental effects of fetal COVID exposure Oct 17, 2024 video
Nipocalimab Shows Sustained Efficacy in Myasthenia Gravis Phase III trial met primary endpoint at 6 months Oct 16, 2024
Anti-CD19 Monoclonal Antibody Shows Positive Results in Myasthenia Gravis Topline phase III data show inebilizumab met primary endpoint Oct 15, 2024
Alzheimer's-Heparin Link; Two Phases of Alzheimer's Damage; Prion Disease Testing News and commentary from the world of neurology and neuroscience Oct 15, 2024
Alzheimer's Drug in Smaller Vial Sizes Could Save Medicare Hundreds of Millions Nearly 6% of lecanemab may be discarded each year Oct 14, 2024
Loneliness Tied to Alzheimer's and Dementia Risk Feeling lonely also linked with cognitive impairment that's not dementia, meta-analysis shows Oct 11, 2024
Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk 10% of patients in trials leading to eli-cel's approval developed MDS or AML Oct 09, 2024
Some Cancers Occur More Frequently in Multiple Sclerosis Patients Bladder, brain, and cervical cancer risks were higher in people with MS Oct 09, 2024
Liberal Blood Transfusions Deliver Brain Function Benefit for the Critically Ill Fewer cerebral ischemic events also observed with care teams quicker to give blood Oct 09, 2024
One Way to Spot Early Cognitive Decline? Medicare Wellness Visits Annual evaluation tied to timelier mild cognitive impairment diagnoses Oct 09, 2024
How the Brain Clears Waste; Masked Benzodiazepine Taper; New Hope for PML News and commentary from the world of neurology and neuroscience Oct 08, 2024
Low-Dose Lithium Tested in Long COVID No benefit for brain fog or fatigue, but higher doses may have promise Oct 02, 2024
Hearing Loss-Cognition Link; Circadian Brain Changes; Repetitive Head Impact Markers News and commentary from the world of neurology and neuroscience Oct 01, 2024
Neurocognitive Side Effects of Brain Radiation Subside for Many, Analysis Shows In three trials, about 40% of patients with brain metastases recovered neurocognitive function Oct 01, 2024
Brett Favre's Parkinson's: 'Hell, I Wrote the Book on Head Trauma' What we know -- and don't know -- about pro football and brain disorders Sep 27, 2024
NIH Neuroscience Leader Committed Research Misconduct, Agency Says Longtime NIA researcher investigated synaptic damage in neurodegenerative disorders Sep 26, 2024
Sexual and Gender Minorities More Likely to Have Adverse Brain Outcomes Some LGBTQ+ groups have higher likelihood of dementia Sep 25, 2024
Fluoride in Water Poses Enough Risk to Kids' IQ to Merit EPA Action, Judge Says Ruling is a blow to practice hailed as one of the greatest achievements in public health Sep 25, 2024
Second Drug OK'd for Ultra-Rare Neurodegenerative Disease FDA approves levacetylleucine (Aqneursa) for Niemann-Pick disease type C Sep 25, 2024
Flavonoid-Dementia Link; Political Beliefs and the Brain; Ethics of Brain Biopsies News and commentary from the world of neurology and neuroscience Sep 24, 2024
One in Three Former NFL Players Believe They Have CTE About 25% of men who thought they had CTE reported feeling suicidal Sep 23, 2024
McDonald Criteria Revisions Signal Shift Toward MS as a Biologically Based Disease Some cases of radiologically isolated syndrome will be considered multiple sclerosis Sep 23, 2024
